Ambulantes Krebszentrum Hamburg

Hamburg 22527

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, NSCLC, Non-small Cell Lung Cancer

Studies at this site

• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed